Is anyone on this site enrolled, or about to enroll, in the bispecific t-cell engager (BiTE) trials involving Regeneron, Harpoon, or Amgen?
Thanks in advance.
Is anyone on this site enrolled, or about to enroll, in the bispecific t-cell engager (BiTE) trials involving Regeneron, Harpoon, or Amgen?
Thanks in advance.
My Oncologist tells me I may now want to consider clinical trials as I have now failed several treatments over the last 2 1/2 + years.
I am now researching my options and have been told about promising BITE trials. Looking at Regeneron + Cemiplimab at Columbia Presbyterian, AMG160 at MSK, and others at Weill Cornell and possibly Yale.
Of course I will need to initially find out if I would even qualify for any of them.
I thought there would have been more responses to your post. Maybe this technology is just too new.
Do you have any update since your post 6 months ago?
Have you looked into trials for AR resistance?
Like ARV 110?
There are a couple like that. Also BAT. Have you given it any thoughts. I’m also BRCA2+